Ta-Jen Wu

Synthetic Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Increases Plasma Levels of Adiponectin in Type 2 Diabetic Patients

Wei‐Shiung Yang, Chi-Yuan Jeng, Ta-Jen Wu et al. · Diabetes Care · 2002 · 408 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Studies on the microspheres comprised of reconstituted collagen and hydroxyapatite

Ta-Jen Wu, Hsiu-Hsuan Huang, Cheng-Wen Lan et al. · Biomaterials · 2003 · 132 citations

Engineering, Bioengineering, Biomedical Engineering +12

Urinary Free Cortisol and Cortisone Determined by High Performance Liquid Chromatography in the Diagnosis of Cushing’s Syndrome¹

Ching‐Ling Lin, Ta-Jen Wu, Dwaine Machacek et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 130 citations · Full text

Medicine, Endocrinology, Clinical Pharmacology +15

Epidemiologic study of type 2 diabetes in Taiwan

Chih‐Jen Chang, Feng‐Hwa Lu, Yi‐Ching Yang et al. · Diabetes Research and Clinical Practice · 2000 · 106 citations

Medicine, Endocrinology, Internal Medicine +9

Prevalence and Risk Factors of Diabetic Retinopathy Among Noninsulin-dependent Diabetic Subjects

Muh‐Shy Chen, Chie-Shung Kao, Chih‐Jen Chang et al. · American Journal of Ophthalmology · 1992 · 105 citations

Medicine, Ophthalmology, Diabetology +14